News

The CERAB technique (covered endovascular reconstruction of the aortic bifurcation) in combination with the BeGraft aortic and two BeGraft peripheral stents provide a treatment option especially for high-risk patients for whom open surgery is...

The one-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) Trial in individuals with aortic stenosis (AS) with small aortic annuli (SAA) demonstrated noninferior clinical outcomes and superior valve performance as...

Study author Dr. Ki Hong Lee of Chonnam National University Hospital, Gwangju, Republic of Korea said: “Patients with diabetes tend to put pressure on the metatarsal area of the foot, rather than the heel. This way of walking encourages...

This is the first study to analyze the impact of inter-atrial shunts in patients with both reduced and preserved LVEF and the first to show different outcomes in these two groups.  “Although further studies are required to confirm our...

The research assessed the prevalence of cardiovascular disease (CVD) risk factors and the use of preventative CVD medications over the past 20+ years in a large Midwest STEMI system. Data included in the study were from 2003 through 2022 in...

Johnson & Johnson and Shockwave Medical, Inc. announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335.00 per share in cash, corresponding to an...

For nearly two decades, CRF® has led the way in pioneering transcatheter therapies for structural heart disease at TVT®. New York Valves marks the next iteration of this legacy, featuring three days of transformative research and techniques...

The research team analyzed deaths after PCI occurring at 39 Michigan hospitals participating in BMC2 between 2012 and 2014. These hospitals use procedural and outcome data to inform quality projects to improve care and patient outcomes. 

The trial will enroll between 250-500 randomized patients undergoing transcatheter aortic valve replacement (TAVR) in the USA and Europe with the ProtEmbo® System, an innovative next generation cerebral embolic protection device (CEP)...

Concept Medical has been granted "IDE Approval" from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of...